KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Non-Current Assets (2019 - 2026)

GoodRx Holdings' Non-Current Assets history spans 7 years, with the latest figure at $761.0 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets rose 4.41% to $761.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.0 billion, a 4.87% increase, with the full-year FY2025 number at $761.0 million, up 4.41% from a year prior.
  • Non-Current Assets hit $761.0 million in Q4 2025 for GoodRx Holdings, roughly flat from $760.0 million in the prior quarter.
  • Over the last five years, Non-Current Assets for GDRX hit a ceiling of $772.8 million in Q2 2023 and a floor of $387.6 million in Q1 2021.
  • Historically, Non-Current Assets has averaged $673.7 million across 5 years, with a median of $718.6 million in 2023.
  • Biggest five-year swings in Non-Current Assets: skyrocketed 53.89% in 2021 and later decreased 6.21% in 2024.
  • Tracing GDRX's Non-Current Assets over 5 years: stood at $518.8 million in 2021, then surged by 32.03% to $684.9 million in 2022, then grew by 4.54% to $716.0 million in 2023, then rose by 1.79% to $728.8 million in 2024, then increased by 4.41% to $761.0 million in 2025.
  • Business Quant data shows Non-Current Assets for GDRX at $761.0 million in Q4 2025, $760.0 million in Q3 2025, and $768.1 million in Q2 2025.